Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Avorn

Showing results (81-90 of 184) with videos related to

Pageof 19
Sort By:
Epidemiology (Cambridge, Mass.)|October 27, 2001
Paradoxical relations of drug treatment with mortality in older personsR J Glynn, E L Knight, R Levin, et al.
Annals of the Rheumatic Diseases|August 31, 2007
Uric acid lowering therapy: prescribing patterns in a large cohort of older adultsD H Solomon, J Avorn, R Levin, et al.
Archives of Internal Medicine|February 1, 1992
Cardiovascular responses to phlebotomy and sitting in middle-aged and elderly subjectsG A Kuchel, J Avorn, M J Reed, et al.
Journal of the American Geriatrics Society|September 1, 1997
Physician attitudes concerning warfarin for stroke prevention in atrial fibrillation: results of a survey of long-term care practitionersJ Monette, J H Gurwitz, P A Rochon, et al.
Archives of Neurology|September 1, 1996
Variability in length of hospitalization for stroke. The role of managed care in an elderly populationM Monane, D S Kanter, R J Glynn, et al.
The New England Journal of Medicine|August 27, 1987
Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equityS B Soumerai, J Avorn, D Ross-Degnan, et al.
Journal of the American Geriatrics Society|July 1, 1990
Pygmalion in the nursing home. The effects of caregiver expectations on patient outcomesL A Learman, J Avorn, D E Everitt, et al.
Clinical Pharmacology and Therapeutics|July 16, 2010
Refilling and switching of antiepileptic drugs and seizure-related eventsJ J Gagne, J Avorn, W H Shrank, et al.
JAMA|July 25, 1990
Nonsteroidal anti-inflammatory drug-associated azotemia in the very oldJ H Gurwitz, J Avorn, D Ross-Degnan, et al.
Annals of Internal Medicine|May 20, 2000
Cost-effectiveness of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor therapy in older patients with myocardial infarctionD A Ganz, K M Kuntz, G A Jacobson, et al.
Pageof 19

Showing results (81-90 of 184) with videos related to

Sort By:
Pageof 19
Epidemiology (Cambridge, Mass.)|October 27, 2001
Paradoxical relations of drug treatment with mortality in older personsR J Glynn, E L Knight, R Levin, et al.
Annals of the Rheumatic Diseases|August 31, 2007
Uric acid lowering therapy: prescribing patterns in a large cohort of older adultsD H Solomon, J Avorn, R Levin, et al.
Archives of Internal Medicine|February 1, 1992
Cardiovascular responses to phlebotomy and sitting in middle-aged and elderly subjectsG A Kuchel, J Avorn, M J Reed, et al.
Journal of the American Geriatrics Society|September 1, 1997
Physician attitudes concerning warfarin for stroke prevention in atrial fibrillation: results of a survey of long-term care practitionersJ Monette, J H Gurwitz, P A Rochon, et al.
Archives of Neurology|September 1, 1996
Variability in length of hospitalization for stroke. The role of managed care in an elderly populationM Monane, D S Kanter, R J Glynn, et al.
The New England Journal of Medicine|August 27, 1987
Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equityS B Soumerai, J Avorn, D Ross-Degnan, et al.
Journal of the American Geriatrics Society|July 1, 1990
Pygmalion in the nursing home. The effects of caregiver expectations on patient outcomesL A Learman, J Avorn, D E Everitt, et al.
Clinical Pharmacology and Therapeutics|July 16, 2010
Refilling and switching of antiepileptic drugs and seizure-related eventsJ J Gagne, J Avorn, W H Shrank, et al.
JAMA|July 25, 1990
Nonsteroidal anti-inflammatory drug-associated azotemia in the very oldJ H Gurwitz, J Avorn, D Ross-Degnan, et al.
Annals of Internal Medicine|May 20, 2000
Cost-effectiveness of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor therapy in older patients with myocardial infarctionD A Ganz, K M Kuntz, G A Jacobson, et al.
Pageof 19